PanGen Biotech Inc. (KOSDAQ:222110)

PanGen Biotech Revenue

PanGen Biotech had revenue of 3.73B KRW in the quarter ending March 31, 2026, with 8.43% growth. This brings the company's revenue in the last twelve months to 13.71B, down -6.37% year-over-year. In the year 2025, PanGen Biotech had annual revenue of 13.42B, down -8.56%.

• Revenue (ttm): 13.71B
• Revenue Growth: -6.37%
• P/S Ratio: 4.58
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 62.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.42B	-1.26B	-8.56%
Dec 31, 2024	14.67B	7.36B	100.58%
Dec 31, 2023	7.32B	814.47M	12.53%
Dec 31, 2022	6.50B	-1.43B	-18.08%
Dec 31, 2021	7.94B	1.74B	28.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 28, 2026

Data Sources Report a data error